(Nasdaq: DFTX) (“Definium” or the “Company”), a late-stage clinical biopharmaceutical company developing a new generation of therapeutics intended to address the underlying causes of psychiatric and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results